Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
19,192,378
-
Share change
-
+489,109
-
Total reported value
-
$2,181,883,515
-
Put/Call ratio
-
0%
-
Price per share
-
$113.68
-
Number of holders
-
268
-
Value change
-
+$57,084,248
-
Number of buys
-
142
-
Number of sells
-
107
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q2 2025
As of 30 Jun 2025,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
268 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,192,378 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, MACQUARIE GROUP LTD, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, CONGRESS ASSET MANAGEMENT CO, Stephens Investment Management Group LLC, Chicago Capital, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
268
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.